An RGS2 3 ' UTR polymorphism is associated with preeclampsia in overweight women

Show full item record



Permalink

http://hdl.handle.net/10138/167316

Citation

Karppanen , T , Kaartokallio , T , Klemetti , M M , Heinonen , S , Kajantie , E , Kere , J , Kivinen , K , Pouta , A , Staff , A C & Laivuori , H 2016 , ' An RGS2 3 ' UTR polymorphism is associated with preeclampsia in overweight women ' , BMC Genetics , vol. 17 , 121 . https://doi.org/10.1186/s12863-016-0428-8

Title: An RGS2 3 ' UTR polymorphism is associated with preeclampsia in overweight women
Author: Karppanen, Tiina; Kaartokallio, Tea; Klemetti, Miira M.; Heinonen, Seppo; Kajantie, Eero; Kere, Juha; Kivinen, Katja; Pouta, Anneli; Staff, Anne Cathrine; Laivuori, Hannele
Contributor: University of Helsinki, Medicum
University of Helsinki, Clinicum
University of Helsinki, Clinicum
University of Helsinki, Children's Hospital
University of Helsinki, Juha Kere / Principal Investigator
University of Helsinki, Institute for Molecular Medicine Finland
Date: 2016-08-24
Language: eng
Number of pages: 7
Belongs to series: BMC Genetics
ISSN: 1471-2156
URI: http://hdl.handle.net/10138/167316
Abstract: Background: Preeclampsia is a common and heterogeneous vascular syndrome of pregnancy. Its genetic risk profile is yet unknown and may vary between individuals and populations. The rs4606 3'UTR polymorphism of the Regulator of G-protein signaling 2 gene (RGS2) in the mother has been implicated in preeclampsia as well as in the development of chronic hypertension after preeclampsia. The RGS2 protein acts as an inhibitor of physiological vasoconstrictive pathways, and a low RGS2 level is associated with hypertension and obesity, two conditions that predispose to preeclampsia. We genotyped the rs4606 polymorphism in 1339 preeclamptic patients and in 697 controls from the Finnish Genetics of Preeclampsia Consortium (FINNPEC) cohort to study the association of the variant with preeclampsia. Results: No association between rs4606 and preeclampsia was detected in the analysis including all women. However, the polymorphism was associated with preeclampsia in a subgroup of overweight women (body mass index >= 25 kg/m(2), and <30 kg/m(2)) (dominant model; odds ratio, 1.64; 95 % confidence interval, 1.10-2.42). Conclusions: Our results suggest that RGS2 might be involved in the pathogenesis of preeclampsia particularly in overweight women and contribute to their increased risk for hypertension and other types of cardiovascular disease later in life.
Subject: Preeclampsia
Pregnancy
Regulator of G-protein signaling 2
Candidate gene study
OBESITY-RELATED HYPERTENSION
BLOOD-PRESSURE
METABOLIC SYNDROME
ANGIOTENSIN-II
CARDIOVASCULAR-DISEASE
C1114G POLYMORPHISM
RISK-FACTORS
PREGNANCY
ANXIETY
METAANALYSIS
3111 Biomedicine
3121 General medicine, internal medicine and other clinical medicine
3123 Gynaecology and paediatrics
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
art_3A10.1186_2Fs12863_016_0428_8.pdf 576.1Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record